Evangelia‐Ourania Fourkala

发表

The sex hormone system in carriers of BRCA1/2 mutations: a case-control study.

I. Jacobs, U. Menon, M. Widschwendter, 2013, The Lancet. Oncology.

Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence

V. Beral, Jane Green, R. Collins, 2019, The Lancet.

Association of skirt size and postmenopausal breast cancer risk in older women: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

M. Parmar, I. Jacobs, U. Menon, 2014, BDJ.

Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women

I. Jacobs, U. Menon, A. Gentry-Maharaj, 2011, Endocrine-related cancer.

A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival

Rebecca Hardy, Martin Widschwendter, Diana Kuh, 2014, Genome Medicine.

HOXA methylation in normal endometrium from premenopausal women is associated with the presence of ovarian cancer: A proof of principle study

Martin Widschwendter, Rupali Arora, Usha Menon, 2009, International journal of cancer.

Diagnostic routes and time intervals for ovarian cancer in nine international jurisdictions; findings from the International Cancer Benchmarking Partnership (ICBP)

C. Anandan, A. Gavin, U. Menon, 2022, British Journal of Cancer.

Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies

Heather Eliassen, Karen Canfell, Julian Peto, 2012, The Lancet. Oncology.

Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer

K. Baggerly, R. Bast, D. Bowtell, 2017, Clinical Cancer Research.

Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women's cancers.

M. Widschwendter, Allison Jones, M. Lechner, 2010, Epigenomics.

Novel risk models for early detection and screening of ovarian cancer

I. Jacobs, U. Menon, A. Ryan, 2016, Oncotarget.

Serum CA19-9 Is Significantly Upregulated up to 2 Years before Diagnosis with Pancreatic Cancer: Implications for Early Disease Detection

Usha, I. Jacobs, S. Apostolidou, 2014, Clinical Cancer Research.

A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival

A. Teschendorff, I. Jacobs, U. Menon, 2014, Genome Medicine.

DNA methylation of polycomb group target genes in cores taken from breast cancer centre and periphery

I. Jacobs, U. Menon, M. Burnell, 2010, Breast Cancer Research and Treatment.

Cancer-associated autoantibodies to MUC1 and MUC4—A blinded case–control study of colorectal cancer in UK collaborative trial of ovarian cancer screening

I. Jacobs, U. Menon, A. Gentry-Maharaj, 2013, International journal of cancer.

Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS)

I. Jacobs, U. Menon, A. Ryan, 2016, Steroids.

Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies

F. Kronenberg, E. Fung, I. Jacobs, 2014, Proteomics. Clinical applications.

Aberrant regulation of RANKL/OPG in women at high risk of developing breast cancer

A. Teschendorff, I. Jacobs, U. Menon, 2016, Oncotarget.

Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus

D. Tuveson, I. Jacobs, U. Menon, 2015, Clinical Cancer Research.

Metabolic Profiling of Adiponectin Levels in Adults

Tom R. Gaunt, D. Lawlor, A. Hingorani, 2017, Circulation. Cardiovascular genetics.

Metabolic Profiling of Adiponectin Levels in Adults

Tom R. Gaunt, D. Lawlor, A. Hingorani, 2017, bioRxiv.

Socioeconomic indicators of health inequalities and female mortality: a nested cohort study within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

Hynek Pikhart, Matthew Burnell, Andy Ryan, 2015, BMC Public Health.

MUC16, alias CA125 and ovarian cancer

Aleksandra Gentry-Maharaj, Usha Menon, Evangelia-Ourania Fourkala, 2013 .

An investigation of routes to cancer diagnosis in 10 international jurisdictions, as part of the International Cancer Benchmarking Partnership: survey development and implementation

C. Anandan, A. Gavin, U. Menon, 2016, BMJ Open.

Colorectal cancer ascertainment through cancer registries, hospital episode statistics, and self-reporting compared to confirmation by clinician: A cohort study nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

U. Menon, A. Ryan, A. Gentry-Maharaj, 2019, Cancer epidemiology.

Identifying hopelessness in population research: a validation study of two brief measures of hopelessness

U. Menon, A. Ryan, M. Burnell, 2014, BMJ Open.

Protein Z: A putative novel biomarker for early detection of ovarian cancer

Michael J. Walker, I. Jacobs, U. Menon, 2016, International journal of cancer.

Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples

I. Jacobs, I. Jacobs, U. Menon, 2015, British Journal of Cancer.

Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer

A. Gammerman, I. Jacobs, U. Menon, 2013, British Journal of Cancer.

Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer

K. Baggerly, R. Bast, I. Jacobs, 2019, Cancer Prevention Research.

Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus

D. Tuveson, I. Jacobs, U. Menon, 2015, Clinical Cancer Research.

Alcohol intake and endogenous sex hormones in women: meta-analysis of cohort studies and Mendelian randomization

M. McCullough, J. Cauley, L. Marchand, 2023, Research square.

Serum CA19-9 Is Significantly Upregulated up to 2 Years before Diagnosis with Pancreatic Cancer: Implications for Early Disease Detection

Usha, I. Jacobs, S. Apostolidou, 2014, Clinical Cancer Research.

HOXA methylation in normal endometrium from premenopausal women is associated with the presence of ovarian cancer: A proof of principle study

I. Jacobs, U. Menon, S. Apostolidou, 2009, International journal of cancer.